Laminin 5, 13 and 14 and uses thereof
US6693169B1 · kind B1 · utility
14Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 1999 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | Oct 12, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/78
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention features two members of laminin family, i.e., laminin 13 and laminin 14, the methods of making these molecules, and the methods of using these molecules in treating neural disorders, e.g., retinal disorders. The present invention also features using a preparation of laminin 5 to treat neural disorders, especially disorders associated with retina.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.